Single-dose treatment of uncomplicated urinary tract infections in children. 1984

G E Stahl, and P Topf, and G R Fleisher, and M E Norman, and H W Rosenblum, and A B Gruskin

Thirty-six girls, aged two to 17 years, with culture-proven, acute, uncomplicated lower urinary tract infections and without signs or symptoms of upper urinary tract infection, were randomized to receive either single-dose amoxicillin or conventional therapy for ten days. Twenty-six patients completed the study, ten in the single-dose group and 16 in the conventional therapy group. The patients treated with single-dose therapy had cure rates (70% vs 75%), relapse rates (30% vs 25%), and reinfection rates (0% vs 12%) comparable to those of conventionally treated patients. A significant difference in the induction of resistant organisms was seen between treatment groups (P less than .05). All single-dose relapses were due to failure to clear a sensitive organism from the urinary tract. All relapses on conventional therapy resulted from an initially sensitive organism becoming resistant to amoxicillin during treatment. Single-dose antibiotic therapy of uncomplicated urinary tract infections in children is effective in patients with culture-proven infections selected by clinical criteria, and appears to be safe when combined with conscientious long-term follow up and radiographic evaluation. Single-dose therapy offers the advantage of selecting significantly fewer resistant organisms from the gut flora than do conventional antibiotic regimens.

UI MeSH Term Description Entries
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000658 Amoxicillin A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration. Hydroxyampicillin,Actimoxi,Amoxicillin Anhydrous,Amoxicillin Monopotassium Salt,Amoxicillin Monosodium Salt,Amoxicillin Sodium,Amoxicillin Trihydrate,Amoxicillin, (R*)-Isomer,Amoxicilline,Amoxil,Amoxycillin,BRL-2333,Clamoxyl,Clamoxyl G.A.,Clamoxyl Parenteral,Penamox,Polymox,Trimox,Wymox,BRL 2333,BRL2333

Related Publications

G E Stahl, and P Topf, and G R Fleisher, and M E Norman, and H W Rosenblum, and A B Gruskin
July 1989, Journal of chemotherapy (Florence, Italy),
G E Stahl, and P Topf, and G R Fleisher, and M E Norman, and H W Rosenblum, and A B Gruskin
May 1985, The New Zealand medical journal,
G E Stahl, and P Topf, and G R Fleisher, and M E Norman, and H W Rosenblum, and A B Gruskin
July 1994, International journal of antimicrobial agents,
G E Stahl, and P Topf, and G R Fleisher, and M E Norman, and H W Rosenblum, and A B Gruskin
January 1985, The New Zealand medical journal,
G E Stahl, and P Topf, and G R Fleisher, and M E Norman, and H W Rosenblum, and A B Gruskin
September 1972, Lakartidningen,
G E Stahl, and P Topf, and G R Fleisher, and M E Norman, and H W Rosenblum, and A B Gruskin
January 1989, Infection,
G E Stahl, and P Topf, and G R Fleisher, and M E Norman, and H W Rosenblum, and A B Gruskin
September 1985, Archives of internal medicine,
G E Stahl, and P Topf, and G R Fleisher, and M E Norman, and H W Rosenblum, and A B Gruskin
April 1983, The Journal of pediatrics,
G E Stahl, and P Topf, and G R Fleisher, and M E Norman, and H W Rosenblum, and A B Gruskin
July 1985, Acta paediatrica Scandinavica,
G E Stahl, and P Topf, and G R Fleisher, and M E Norman, and H W Rosenblum, and A B Gruskin
November 1988, The Pediatric infectious disease journal,
Copied contents to your clipboard!